Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | ACC

The following are the late-breaking clinical trial presentations presented at the 2016 American College of Cardiology ...

Home February 09, 2016
Home
Technology | Left Atrial Appendage (LAA) Occluders

February 9, 2016 — Boston Scientific Corp. announced the Centers for Medicare and Medicaid Services (CMS) will cover ...

Home February 09, 2016
Home
This illustrates how volanesorsen works to prevent the formation of apoC-III protein. Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the production or functionality of lipoprotein lipase (LPL).
Feature | Pharmaceuticals | Rosanne M. Crooke, Ph.D.

Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the ...

Home January 22, 2016
Home
News | Hypertension

January 4, 2016 — Living with pulmonary arterial hypertension (PH) is challenging, but the chore of treating the rare ...

Home January 04, 2016
Home
Feature | Genetic Testing | Kevin P. Greene, M.D.

Statins are lifesaving medications — they have been shown to greatly reduce heart attack and other related events by ...

Home December 22, 2015
Home
News | ACC

December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...

Home December 22, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III ...

Home December 17, 2015
Home
News | Pharmaceuticals

November 24, 2015 —The U.S. Court of Appeals has overturned a federal circuit court’s decision in The Medicines Company ...

Home November 24, 2015
Home
Technology | Pharmaceuticals

November 24, 2015 – The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals’ ...

Home November 24, 2015
Home
Technology | Cardiac Diagnostics

November 20, 2015 — Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed ...

Home November 20, 2015
Home
wearable Holter monitors, iRhythm, ziopatch, zio patch
Feature | Holter Monitoring Systems | Judy Lenane, RN, MHA

One-third of ischemic strokes are classified as cryptogenic. The classic risk factors for stroke are usually absent ...

Home November 16, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

November 12, 2015 — Preventing blood clots with drugs such as heparin has become a common practice for fighting some ...

Home November 12, 2015
Home
News | Hypertension

November 12, 2015 — A pharmacist-physician collaborative effort to control blood pressure among a diverse group of ...

Home November 12, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new ...

Home November 11, 2015
Home
News | Pulmonary Embolism

November 3, 2015 — Pulmonary embolism (PE) is a potentially life-threatening condition that occurs, for example, when a ...

Home November 03, 2015
Home
Subscribe Now